nodes	percent_of_prediction	percent_of_DWPC	metapath
Mefloquine—HBA1—forebrain—attention deficit hyperactivity disorder	0.0359	0.07	CbGeAlD
Mefloquine—HBA2—forebrain—attention deficit hyperactivity disorder	0.033	0.0643	CbGeAlD
Mefloquine—HBA1—cardiovascular system—attention deficit hyperactivity disorder	0.0303	0.0592	CbGeAlD
Mefloquine—HBA2—cardiovascular system—attention deficit hyperactivity disorder	0.0279	0.0544	CbGeAlD
Mefloquine—HBA1—nervous system—attention deficit hyperactivity disorder	0.0195	0.038	CbGeAlD
Mefloquine—HBA1—central nervous system—attention deficit hyperactivity disorder	0.0188	0.0366	CbGeAlD
Mefloquine—HBA1—cerebellum—attention deficit hyperactivity disorder	0.0183	0.0358	CbGeAlD
Mefloquine—HBA2—nervous system—attention deficit hyperactivity disorder	0.0179	0.0349	CbGeAlD
Mefloquine—HBA2—central nervous system—attention deficit hyperactivity disorder	0.0172	0.0336	CbGeAlD
Mefloquine—ADORA2A—forebrain—attention deficit hyperactivity disorder	0.0172	0.0335	CbGeAlD
Mefloquine—HBA2—cerebellum—attention deficit hyperactivity disorder	0.0168	0.0329	CbGeAlD
Mefloquine—HBA1—brain—attention deficit hyperactivity disorder	0.0149	0.0291	CbGeAlD
Mefloquine—ADORA1—forebrain—attention deficit hyperactivity disorder	0.0148	0.0289	CbGeAlD
Mefloquine—ADORA2A—cardiovascular system—attention deficit hyperactivity disorder	0.0145	0.0283	CbGeAlD
Mefloquine—HBA2—brain—attention deficit hyperactivity disorder	0.0137	0.0267	CbGeAlD
Mefloquine—ADORA1—cardiovascular system—attention deficit hyperactivity disorder	0.0125	0.0244	CbGeAlD
Mefloquine—CYP19A1—forebrain—attention deficit hyperactivity disorder	0.01	0.0196	CbGeAlD
Mefloquine—ADORA1—midbrain—attention deficit hyperactivity disorder	0.00978	0.0191	CbGeAlD
Mefloquine—ACHE—midbrain—attention deficit hyperactivity disorder	0.00972	0.019	CbGeAlD
Mefloquine—ADORA2A—nervous system—attention deficit hyperactivity disorder	0.00931	0.0182	CbGeAlD
Mefloquine—ADORA2A—central nervous system—attention deficit hyperactivity disorder	0.00896	0.0175	CbGeAlD
Mefloquine—ADORA2A—cerebellum—attention deficit hyperactivity disorder	0.00876	0.0171	CbGeAlD
Mefloquine—ADORA1—nervous system—attention deficit hyperactivity disorder	0.00804	0.0157	CbGeAlD
Mefloquine—ADORA1—central nervous system—attention deficit hyperactivity disorder	0.00774	0.0151	CbGeAlD
Mefloquine—ADORA1—cerebellum—attention deficit hyperactivity disorder	0.00757	0.0148	CbGeAlD
Mefloquine—ACHE—cerebellum—attention deficit hyperactivity disorder	0.00752	0.0147	CbGeAlD
Mefloquine—BCHE—forebrain—attention deficit hyperactivity disorder	0.00723	0.0141	CbGeAlD
Mefloquine—ADORA2A—brain—attention deficit hyperactivity disorder	0.00712	0.0139	CbGeAlD
Mefloquine—ADORA1—brain—attention deficit hyperactivity disorder	0.00615	0.012	CbGeAlD
Mefloquine—BCHE—cardiovascular system—attention deficit hyperactivity disorder	0.00612	0.0119	CbGeAlD
Mefloquine—ACHE—brain—attention deficit hyperactivity disorder	0.00611	0.0119	CbGeAlD
Mefloquine—CYP19A1—nervous system—attention deficit hyperactivity disorder	0.00545	0.0106	CbGeAlD
Mefloquine—CYP19A1—central nervous system—attention deficit hyperactivity disorder	0.00525	0.0102	CbGeAlD
Mefloquine—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.00479	0.00935	CbGeAlD
Mefloquine—BCHE—midbrain—attention deficit hyperactivity disorder	0.00478	0.00932	CbGeAlD
Mefloquine—CYP19A1—brain—attention deficit hyperactivity disorder	0.00417	0.00813	CbGeAlD
Mefloquine—BCHE—nervous system—attention deficit hyperactivity disorder	0.00393	0.00766	CbGeAlD
Mefloquine—BCHE—central nervous system—attention deficit hyperactivity disorder	0.00378	0.00738	CbGeAlD
Mefloquine—BCHE—cerebellum—attention deficit hyperactivity disorder	0.0037	0.00721	CbGeAlD
Mefloquine—ABCB1—forebrain—attention deficit hyperactivity disorder	0.00345	0.00673	CbGeAlD
Mefloquine—BCHE—brain—attention deficit hyperactivity disorder	0.003	0.00586	CbGeAlD
Mefloquine—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.00292	0.00569	CbGeAlD
Mefloquine—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.00264	0.00516	CbGeAlD
Mefloquine—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.0026	0.00508	CbGeAlD
Mefloquine—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.00255	0.00497	CbGeAlD
Mefloquine—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.0025	0.00489	CbGeAlD
Mefloquine—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.00245	0.00478	CbGeAlD
Mefloquine—ABCB1—midbrain—attention deficit hyperactivity disorder	0.00228	0.00444	CbGeAlD
Mefloquine—CYP2D6—brain—attention deficit hyperactivity disorder	0.00199	0.00388	CbGeAlD
Mefloquine—ADORA1—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.0019	0.00391	CbGpPWpGaD
Mefloquine—ADORA1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00188	0.00386	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00187	0.00384	CbGpPWpGaD
Mefloquine—ABCB1—nervous system—attention deficit hyperactivity disorder	0.00187	0.00365	CbGeAlD
Mefloquine—ADORA1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00182	0.00373	CbGpPWpGaD
Mefloquine—ABCB1—central nervous system—attention deficit hyperactivity disorder	0.0018	0.00352	CbGeAlD
Mefloquine—HBA2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.0018	0.00369	CbGpPWpGaD
Mefloquine—ADORA1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00179	0.00367	CbGpPWpGaD
Mefloquine—ADORA2A—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00179	0.00366	CbGpPWpGaD
Mefloquine—ACHE—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00178	0.00365	CbGpPWpGaD
Mefloquine—ADORA1—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.00177	0.00364	CbGpPWpGaD
Mefloquine—ADORA2A—Circadian rythm related genes—SLC6A4—attention deficit hyperactivity disorder	0.00177	0.00363	CbGpPWpGaD
Mefloquine—ADORA2A—Circadian rythm related genes—DRD1—attention deficit hyperactivity disorder	0.00177	0.00363	CbGpPWpGaD
Mefloquine—ADORA1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00177	0.00362	CbGpPWpGaD
Mefloquine—ABCB1—cerebellum—attention deficit hyperactivity disorder	0.00176	0.00344	CbGeAlD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00173	0.00355	CbGpPWpGaD
Mefloquine—ADORA2A—Circadian rythm related genes—DRD3—attention deficit hyperactivity disorder	0.00172	0.00352	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00172	0.00352	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00171	0.00352	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00171	0.0035	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00171	0.0035	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.0017	0.00349	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00168	0.00345	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00168	0.00344	CbGpPWpGaD
Mefloquine—ADORA2A—Circadian rythm related genes—DRD4—attention deficit hyperactivity disorder	0.00167	0.00342	CbGpPWpGaD
Mefloquine—ADORA1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00165	0.00338	CbGpPWpGaD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00161	0.0033	CbGpPWpGaD
Mefloquine—BCHE—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00159	0.00325	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00156	0.0032	CbGpPWpGaD
Mefloquine—ADORA2A—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00156	0.0032	CbGpPWpGaD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00156	0.0032	CbGpPWpGaD
Mefloquine—ADORA2A—Circadian rythm related genes—DRD2—attention deficit hyperactivity disorder	0.00155	0.00318	CbGpPWpGaD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00153	0.00314	CbGpPWpGaD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00153	0.00314	CbGpPWpGaD
Mefloquine—ACHE—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00153	0.00314	CbGpPWpGaD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00151	0.00311	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00151	0.0031	CbGpPWpGaD
Mefloquine—ADORA2A—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00145	0.00298	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00145	0.00297	CbGpPWpGaD
Mefloquine—ABCB1—brain—attention deficit hyperactivity disorder	0.00143	0.00279	CbGeAlD
Mefloquine—ACHE—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00142	0.00291	CbGpPWpGaD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00141	0.00289	CbGpPWpGaD
Mefloquine—ADORA2A—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00141	0.00288	CbGpPWpGaD
Mefloquine—ADORA2A—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00138	0.00283	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00136	0.0028	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—COMT—attention deficit hyperactivity disorder	0.00136	0.0028	CbGpPWpGaD
Mefloquine—ADORA2A—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00136	0.0028	CbGpPWpGaD
Mefloquine—BCHE—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00136	0.0028	CbGpPWpGaD
Mefloquine—ACHE—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00136	0.00279	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.00136	0.00278	CbGpPWpGaD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00134	0.00274	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00132	0.00271	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00131	0.00269	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.0013	0.00266	CbGpPWpGaD
Mefloquine—ADORA2A—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00127	0.00261	CbGpPWpGaD
Mefloquine—BCHE—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00127	0.0026	CbGpPWpGaD
Mefloquine—ACHE—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00127	0.0026	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00126	0.00258	CbGpPWpGaD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00124	0.00255	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00123	0.00252	CbGpPWpGaD
Mefloquine—ACHE—ATF-2 transcription factor network—EP300—attention deficit hyperactivity disorder	0.00123	0.00252	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00123	0.00252	CbGpPWpGaD
Mefloquine—BCHE—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00122	0.00249	CbGpPWpGaD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.0012	0.00247	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00119	0.00244	CbGpPWpGaD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00118	0.00243	CbGpPWpGaD
Mefloquine—ACHE—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00117	0.0024	CbGpPWpGaD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00117	0.0024	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00117	0.00239	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00117	0.00239	CbGpPWpGaD
Mefloquine—ADORA1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00115	0.00237	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00115	0.00236	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00114	0.00234	CbGpPWpGaD
Mefloquine—BCHE—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00113	0.00232	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00112	0.00229	CbGpPWpGaD
Mefloquine—CYP19A1—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00112	0.00229	CbGpPWpGaD
Mefloquine—CYP19A1—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00111	0.00227	CbGpPWpGaD
Mefloquine—CYP19A1—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.0011	0.00226	CbGpPWpGaD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00109	0.00223	CbGpPWpGaD
Mefloquine—ACHE—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00109	0.00223	CbGpPWpGaD
Mefloquine—ACHE—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.00108	0.00221	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00107	0.0022	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.00107	0.0022	CbGpPWpGaD
Mefloquine—ACHE—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00107	0.00219	CbGpPWpGaD
Mefloquine—BCHE—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00105	0.00214	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—COMT—attention deficit hyperactivity disorder	0.00103	0.00212	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.00103	0.00211	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00102	0.00209	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.001	0.00206	CbGpPWpGaD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000988	0.00203	CbGpPWpGaD
Mefloquine—BCHE—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000972	0.00199	CbGpPWpGaD
Mefloquine—ACHE—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000971	0.00199	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00097	0.00199	CbGpPWpGaD
Mefloquine—BCHE—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000961	0.00197	CbGpPWpGaD
Mefloquine—BCHE—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000954	0.00196	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00095	0.00195	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000947	0.00194	CbGpPWpGaD
Mefloquine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000932	0.00191	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000917	0.00188	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000902	0.00185	CbGpPWpGaD
Mefloquine—ADORA2A—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00089	0.00183	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00089	0.00183	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000881	0.00181	CbGpPWpGaD
Mefloquine—BCHE—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000866	0.00178	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000863	0.00177	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000853	0.00175	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000829	0.0017	CbGpPWpGaD
Mefloquine—ACHE—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000825	0.00169	CbGpPWpGaD
Mefloquine—ACHE—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000819	0.00168	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000784	0.00161	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000776	0.00159	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000775	0.00159	CbGpPWpGaD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000763	0.00156	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000752	0.00154	CbGpPWpGaD
Mefloquine—ADORA1—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	0.000746	0.00153	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000746	0.00153	CbGpPWpGaD
Mefloquine—BCHE—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000736	0.00151	CbGpPWpGaD
Mefloquine—BCHE—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000731	0.0015	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000693	0.00142	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000677	0.00139	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000674	0.00138	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000671	0.00138	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00066	0.00135	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00066	0.00135	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000659	0.00135	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000653	0.00134	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000652	0.00134	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000647	0.00133	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000629	0.00129	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000623	0.00128	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00061	0.00125	CbGpPWpGaD
Mefloquine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000609	0.00125	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000607	0.00125	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000606	0.00124	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000599	0.00123	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000598	0.00123	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000592	0.00121	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—EP300—attention deficit hyperactivity disorder	0.000585	0.0012	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000581	0.00119	CbGpPWpGaD
Mefloquine—ADORA2A—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	0.000576	0.00118	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000576	0.00118	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000551	0.00113	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000535	0.0011	CbGpPWpGaD
Mefloquine—CYP19A1—Integrated Breast Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000532	0.00109	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000523	0.00107	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00052	0.00107	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000518	0.00106	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00051	0.00105	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000509	0.00104	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000503	0.00103	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.0005	0.00103	CbGpPWpGaD
Mefloquine—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000498	0.00102	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000497	0.00102	CbGpPWpGaD
Mefloquine—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000495	0.00102	CbGpPWpGaD
Mefloquine—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000492	0.00101	CbGpPWpGaD
Mefloquine—ABCB1—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.000488	0.001	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000486	0.000997	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000479	0.000983	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000471	0.000965	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000469	0.000961	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.000466	0.000956	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000463	0.000949	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000458	0.000938	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000457	0.000937	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000457	0.000937	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—EP300—attention deficit hyperactivity disorder	0.000444	0.00091	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000443	0.000909	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000426	0.000873	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000425	0.000872	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.0004	0.00082	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000386	0.000792	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000372	0.000763	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.00036	0.000739	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000354	0.000726	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000353	0.000725	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.00035	0.000717	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000343	0.000703	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000343	0.000703	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000337	0.000692	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000328	0.000673	CbGpPWpGaD
Mefloquine—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000326	0.000668	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000326	0.000668	CbGpPWpGaD
Mefloquine—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000324	0.000664	CbGpPWpGaD
Mefloquine—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000321	0.000659	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000315	0.000646	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000315	0.000646	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000314	0.000643	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00031	0.000636	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000309	0.000633	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000306	0.000628	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000306	0.000628	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000301	0.000617	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000298	0.000611	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000288	0.000591	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000287	0.000589	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00028	0.000574	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000278	0.00057	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000274	0.000562	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000273	0.00056	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.00027	0.000554	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000261	0.000535	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000252	0.000517	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000251	0.000516	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000245	0.000502	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00024	0.000492	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000233	0.000478	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000228	0.000468	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000227	0.000466	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000216	0.000444	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000209	0.000428	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—COMT—attention deficit hyperactivity disorder	0.000208	0.000426	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000206	0.000423	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000204	0.000418	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.0002	0.00041	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000191	0.000392	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.00019	0.000389	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—COMT—attention deficit hyperactivity disorder	0.000185	0.00038	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000184	0.000378	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000184	0.000377	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000179	0.000366	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000176	0.000361	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000149	0.000306	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000149	0.000306	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000147	0.000301	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000141	0.000289	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000141	0.000289	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000138	0.000284	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000137	0.00028	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000133	0.000273	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000129	0.000264	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000121	0.000248	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000119	0.000245	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000114	0.000233	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000112	0.000231	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000107	0.00022	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	9.33e-05	0.000191	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	9.2e-05	0.000189	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	9.2e-05	0.000189	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	9.05e-05	0.000186	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	9.05e-05	0.000186	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	8.98e-05	0.000184	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—EP300—attention deficit hyperactivity disorder	8.91e-05	0.000183	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	8.52e-05	0.000175	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	8.46e-05	0.000174	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	8.41e-05	0.000173	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—EP300—attention deficit hyperactivity disorder	8.19e-05	0.000168	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—EP300—attention deficit hyperactivity disorder	7.95e-05	0.000163	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	7.35e-05	0.000151	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	7e-05	0.000144	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	5.57e-05	0.000114	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	5.53e-05	0.000113	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	3.88e-05	7.96e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	3.66e-05	7.5e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	2.39e-05	4.9e-05	CbGpPWpGaD
